To support COVID-19 research, Sino Biological has developed a large collection of antibodies against different antigens of SARS-CoV-2. These antibodies can be used to detect and/or neutralize the virus in a variety of assays including ELISA, western blot, Immunofluorescent staining, Immunohistochemistry, SPR (Biacore and Octet), pseudovirus infection, and potentially in vivo animal studies. |
SARS-CoV-2 ANTIBODY GUIDE SARS-CoV-2 ANTIBODY GUIDE |
To support COVID-19 research, Sino Biological has developed a large collection of antibodies against different antigens of SARS-CoV-2. These antibodies can be used to detect and/or neutralize the virus in a variety of assays including ELISA, western blot, Immunofluorescent staining, Immunohistochemistry, SPR (Biacore and Octet), pseudovirus infection, and potentially in vivo animal studies. |
SARS-CoV-2 ANTIBODY GUIDE SARS-CoV-2 ANTIBODY GUIDE |
SARS-CoV-2 Antibodies | SARS-CoV-2 Antigens |
This week, Sino Biological launched three new antibodies aganist SARS-CoV-2 nucleocapsid. All of them can recognize SARS-CoV-2 nucleocapsid with High specificity without cross-reactivity with MERS-CoV, 229E, NL63, HKU1, OC43 assessed in ELISA.
40588-MM123 | Anti-SARS-CoV-2 nucleocapsid, Mouse MAb |
40588-MM124 | Anti-SARS-CoV-2 nucleocapsid, Mouse MAb |
40588-R001 | Anti-SARS-CoV-2 nucleocapsid, Rabbit MAb |
They can be used as detection antibody or capture antibody in ELISA assay. Sino Biological has validated the matched antibody pairs for recommendation.
Antibody Pairs | Capture Ab | Detection Ab |
Pair I | 40143-MM05 | 40588-R001 |
Pair II | 40588-MM123 | 40588-R001 |
Pair III | 40143-R040 | 40588-R001 |
Pair IV | 40588-MM123 | 40588-MM124 |
Antibody Pairs | Capture Ab | Detection Ab |
Pair V | 40143-R040 | 40588-MM124 |
Pair VI | 40588-MM124 | 40143-R040 |
Pair VII | 40143-R004 | 40588-R001 |
Pair VIII | 40143-R004 | 40588-MM124 |
Sino Biological has released the world-first ELISA kits for the detection of SARS-CoV-2 N and S proteins. These assays may be used to quantify antigens on the surface of SARS-CoV-2 and/or pseudovirus, as well as antigens expressed recombinantly. They can be use to detection or diagnostic tools development.
![]() |
|
|||||||||||||||||
S ELISA Kit (KIT40591)![]() |
|
Antibody Pairs for N Protein | ||
Antibody Pairs | Capture Ab | Detection Ab |
Pair I | 40143-R004 | 40143-R040 |
Pair II | 40143-MM05 | 40143-R001 |
Pair III | 40143-MM08 | 40143-R004 |
Antibody Pairs for S Protein | ||
Antibody Pairs | Capture Ab | Detection Ab |
Pair I | 40150-D003 | 40150-D001 |
Pair II | 40150-D002 | 40150-D004 |
Pair III | 40150-D006 | 40591-MM43 |
Antigen | Type | Cat# | Description |
S1 | Mouse MAb | 40591-MM43 | SARS-CoV-2 Neutralizing Antibody |
RBD | Mouse MAb | 40592-MM57 | |
RBD | Rabbit MAb | 40592-R001 |
This chimeric antibody specifically recognizing the S2 domain of SARS-CoV-2
Cat # | 40590-D001 |
Description | SARS-CoV-2 Spike S2 Antibody |
Type | Chimeric MAb |
Ig Type | mouse (variable region) / human (kappa / IgG1 constant) |
Cross-reactivity | No cross-reactivity in ELISA with SARS-CoV-2 (2019-nCoV) Spike S1 (Cat# 40591-V08H) SARS-CoV-2 (2019-nCoV) Spike RBD (Cat# 40592-V05H) |
Validated Applications | |||
IF (40150-R007) - Pseudovirus Validated | WB (40143-R019) | ||
![]() SARS-CoV-2 Spike in ACE2-overexpressed 293T cells, infected (left) or noninfected (right) by 2019-nCOV pseudovirus. |
![]() |
Sample: 2019-nCoV NP Protein (Cat# 40588-V08B) Lane A: 30ng Lane B: 10ng Lane C: 5ng Lane D: 2ng Lane E: 1ng Lane F: 0.5ng |
Validated Applications | ||
IF (40150-R007) - Pseudovirus Validated | ||
![]() SARS-CoV-2 Spike in ACE2-overexpressed 293T cells, infected (left) or noninfected (right) by 2019-nCOV pseudovirus. |
||
WB (40143-R019) | ||
![]() Sample: 2019-nCoV NP Protein (Cat# 40588-V08B) Lane A: 30ng Lane B: 10ng Lane C: 5ng Lane D: 2ng Lane E: 1ng Lane F: 0.5ng |
Cat# | Antigen | More | |||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|